FDA Approves Nemolizumab for Individuals with Atopic Dermatitis
This approval announcement by Galderma follows the previous FDA approval of nemolizumab for prurigo nodularis.
Related Articles
Fast-Track DEA Training—Get Your Exclusive, AMA Members-Only Certificate for Opioid and Substance Use Disorder CME!
AMA members have access to curated, mini-CME tracks designed to help physicians meet the educational criteria for the one time, 8-hour training requirement for all…
Invasive Treatment Strategy for Older Patients with Myocardial Infarction | NEJM
Whether a conservative strategy of medical therapy alone or a strategy of medical therapy plus invasive treatment is more beneficial in older adults with non–ST-segment…
Is Parenting the Latest Health Hazard?
The surgeon general’s advisory on the mental health of parents turned the spotlight on the stress of caregiving in today’s complex world. Try these strategies…
Best of 2024: SGLT2 Inhibitor Protective Effects in Lupus | RheumNow
Systemic lupus erythematosus (SLE) outcomes were assessed based on whether they received sodium-glucose co-transporter 2 inhibitors (SGLT2i), in the setting of comorbid type 2 diabetes…
Samsung just unveiled a sleek new OLED smart monitor (and it’s not just for gamers)
The Smart Monitor M9 is the company’s first OLED smart monitor intended for a diverse audience, with a 165Hz refresh rate and ultra-thin bezels.
Medicaid Personal Needs Allowances
This Viewpoint discusses the need to increase the federal personal needs allowance floor and index the floor to inflation to improve the quality of life…
5-Star Review of Ocular Pathology, 9th Edition – The Bookmark
The book provides a comprehensive review of ocular pathology, updated in this ninth edition to include relevant insights into developing and new diseases. The previous…
Measles outbreak
For each measles case reported in Québec, a public health investigation is conducted. Consult locations, dates and times where exposure may have occurred.
